Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
laxative
|
| gptkbp:activeIngredient |
polyethylene glycol 3350
|
| gptkbp:approvedBy |
gptkb:FDA
1999 |
| gptkbp:ATCCode |
gptkb:A06AD15
|
| gptkbp:brand |
polyethylene glycol 3350
|
| gptkbp:contraindication |
gptkb:bowel_obstruction
allergy to polyethylene glycol |
| gptkbp:dosing |
17 grams dissolved in 4-8 ounces of liquid once daily
|
| gptkbp:form |
powder
|
| gptkbp:genericName |
polyethylene glycol 3350
|
| https://www.w3.org/2000/01/rdf-schema#label |
MiraLAX
|
| gptkbp:legalStatus |
OTC (US)
|
| gptkbp:manufacturer |
gptkb:Bayer
|
| gptkbp:marketedIn |
gptkb:Australia
gptkb:Canada gptkb:United_Kingdom gptkb:United_States |
| gptkbp:mechanismOfAction |
osmotic laxative
|
| gptkbp:onset |
1 to 3 days
|
| gptkbp:OTC |
true
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:prescriptionStatus |
over-the-counter
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gptkb:gasoline
nausea bloating cramping |
| gptkbp:storage |
room temperature
|
| gptkbp:usedFor |
constipation
|
| gptkbp:bfsParent |
gptkb:Bayer_Consumer_Health
|
| gptkbp:bfsLayer |
7
|